Status:
UNKNOWN
Comparative Efficacy and Acceptability of Antimanic Drugs in Acute Mania
Lead Sponsor:
Guiyun Xu
Collaborating Sponsors:
The University of Hong Kong
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Background: Bipolar disorder is one of the most common mental illnesses affecting 1%-4% of the population, and one of the leading causes of worldwide disability. Mania is a condition of excessively e...
Detailed Description
Background: Bipolar disorder is one of the most common mental illnesses affecting 1%-4% of the population, and one of the leading causes of worldwide disability. Mania is a condition of excessively e...
Eligibility Criteria
Inclusion
- with a diagnosis of bipolar I disorder, manic or mixed phase
- equal or more than 18 scores in Young Mania Rating Scale (YMRS)
Exclusion
- Serious general medical illness
- pregnancy and lactation
- given long-acting antipsychotic drug within the last two month
- endocrine disease( e.g.Diabetes and thyrotoxicosis)
- given thyroxine therapy within the last three months or is being given hormone therapy
- sexually active and not using contraceptives
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01893229
Start Date
September 1 2013
End Date
December 1 2015
Last Update
March 17 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Psychiatric Hospital
Guangzhou, Guangdong, China, 510370
2
Guangzhou Psychiatric Hospital
Guangzhou, Guangdong, China, 510370